Pharmaceutical composition for inhalation of dry powder and method for preparing the same

A dry powder inhalation composition with vardenafil and excipients like amino acids and phospholipids addresses the slow onset of oral vardenafil by improving aerosol properties and lung distribution, ensuring rapid drug action.

JP2026539026APending Publication Date: 2026-11-19ASG INSPIRATION LABORATORY (SINGAPORE) PTE LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2026523860
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-11-01
Filing Date
2024-05-30
Publication Date
2026-11-19

AI Technical Summary

Technical Problem

The oral administration of vardenafil results in a limited onset time due to its absorption in the gastrointestinal tract, necessitating a more effective delivery method for faster action.

Method used

A pharmaceutical composition for dry powder inhalation is developed, comprising vardenafil and various pharmaceutically acceptable excipients such as amino acids, polysaccharides, phospholipids, and polylactic acid copolymers, which are spray-dried to form fine particles with controlled shape and size, enhancing aerosol properties for inhalation.

Benefits of technology

The composition achieves improved aerosol properties and shorter onset time by ensuring smaller particle sizes and uniform distribution, facilitating better lung penetration and faster drug action.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2026539026000001_ABST
    Figure 2026539026000001_ABST
Patent Text Reader

Abstract

This invention provides a pharmaceutical composition for inhalation as a dry powder. [Solution] A pharmaceutical composition for dry powder inhalation comprises an active ingredient and a first pharmaceutically acceptable excipient. The active ingredient comprises vardenafil or a pharmaceutically acceptable salt thereof. The first pharmaceutically acceptable excipient comprises amino acids, polysaccharides, phospholipids, polylactic acid, polylactic acid copolymers, or combinations thereof. Some embodiments of the present disclosure further provide a method for preparing a pharmaceutical composition for dry powder inhalation.
Need to check novelty before this filing date? Find Prior Art